Clinical trial
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
NCT04424719 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
- Lead sponsor
- Institut Curie
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 8, 2020
- Completion date
- July 7, 2037
- Enrollment
- 700 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.